Gypto Pharma
↗Khanka, Qalyubia, Egypt
Gypto Pharma, also known as Medicine City, is one of the largest pharmaceutical manufacturing hubs in the Middle East and Africa. Inaugurated in 2021 by the Egyptian government, the facility spans 180,000 square meters and was established to ensure national drug security, end monopolistic practices, and provide high-quality, affordable medications to the Egyptian public.
The company operates as a state-of-the-art CDMO and generic manufacturer with 160 production lines. It is designed to be a regional export hub, attracting international pharmaceutical giants for local manufacturing and technology transfer. Its facilities are built to meet international standards, including those of the FDA and EMA, to facilitate global exports.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic Manufacturing & CDMO
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M (Estimated based on capacity)
Founded:2021
Ownership:government
Status:operating
FUNDING
Stage:Government-funded
Total Raised:Multi-billion EGP investment
Investors:Egyptian State, National Investment Bank
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Generics)
Modalities:Small molecule, Vaccines, Biosimilars, Sterile Injectables, Oral Solids
Active Trials:2
Trial Phases:Phase 4: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Egyptian State (Ministry of Health / Unified Procurement Authority involvement)
Key Partnerships:Abbott (Manufacturing 6 painkillers and antibiotics), Otsuka (Local production and export), Dawah Pharmaceuticals (Strategic alliance for FDA qualification), Sanofi (Local manufacturing collaboration), AstraZeneca (Technology transfer discussions)
COMPETITION
Position:Leader
Competitors:Pharco Pharmaceuticals, EIPICO, Eva Pharma, Sedico, Vacsera
LEADERSHIP
Key Executives:
Dr. Amr Mamdouh - Chairman & CEO
Mohamed Hassan - CFO
Board Members:Dr. Amr Mamdouh
LINKS
Website:gyptopharma.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Gypto Pharma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.